The Shiddiky Laboratory is pursuing studies of the development of multifunctional magnetic nanomaterials based novel nanomachineries for the highly selective isolation and sensitive detection of exosome and exosomal biomarkers in patients with cancer and other diseases.
A novel platform method based on metal-biomolecules affinity interaction (i.e., adsorption) for the analysis of a range of genetic, epigenetic, and proteomic biomarkers in patients with cancers and other diseases. This method can overcome the major technological drawbacks in current biosensing approaches.
Dear Prime Minister, Please lock us down now.
You keep inferring we are heading that way, but is doing it waxing salon by waxing salon, really the way?
#coronavirusau #Lockdownaustralia #covid19australia
My latest column for @10Daily
# https://10daily.com.au/views/a200325gxbmc/lisa-wilkinson-dear-prime-minister-lock-us-down-now-20200325
I am editing a special issue of “Molecules” on Metal Nanoparticles and Their Biosensing Applications. I’ll send personal invitations for your contribution. https://www.mdpi.com/journal/molecules/special_issues/metal_nano_biosens_appli
Congratulations @Nahian @Shiddiky_Aus @muhammad_umer @sns2311 @ExosomeLab for this work.
MicroRNAs in ovarian cancer and recent advances in the development of microRNA-based biosensors - now published in Analyst https://pubs.rsc.org/en/content/articlelanding/2020/an/c9an02263e